To The Moon

$Oklo Inc.(OKLO)$ Oklo Nuclear Power!!! go go go!!!

$APPLIED DIGITAL CORP(APLD)$  taking some profit 

$Palantir Technologies Inc.(PLTR)$   I sell covered call option to make some side income on almost all my underlying shares in hand. However there's 1 stock that I have rarely do that now is PLTR. Used to sell covered call on PLTR before as we know the stock price just kept going up, some of the shares were called away due to the option got into the money and too deep to roll them. Thus decided not to sell anymore CC against the remaining PLTR, in fact will be looking for opportunity to enter some more PLTR when there's any market pull back. 

$BitMine Immersion Technologies Inc.(BMNR)$  $1000 in 30 mins - rare successful scalp from a squeeze!!!

$Ondas Holdings Inc.(ONDS)$ closed half my position..riding the rest until 9ma cross below 50ma? Or crash below ic cloud  I believe it will have some pullback to form handle?hopefully when handle form it won't cause 9ma below 50ma...or below ic cloud Tiger app really need to find a way add ichimoku cloud in mobile app man....I have to switch to other broker to check trend

$BTG 20260116 2.5 CALL$ Literally and metaphorically digging up gold!

$NVDA 20250815 145.0 CALL$ Manually closing position to earn tiger coins as well as to lock in the gains before it turns red.  🤗🤗🤗$NVIDIA(NVDA)$  

$Shopify(SHOP)$ As Shopify Inc. (NYSE: SHOP) prepares to report its second-quarter earnings for fiscal year 2025, investors are sharply divided on whether the e-commerce platform’s stock still offers upside potential—or if the market has already priced in the bullish narrative. Following a remarkable run-up in the first half of 2025, shares of Shopify now sit at a technical crossroads, flirting with a possible double top formation around the $130–$135 resistance zone. Bulls see solid execution, strong GMV growth, and AI-fueled monetization opportunities, while skeptics warn of high valuation multiples and slowing expansion in key markets. With Q2 earnings on deck, the central question is not whether Shopify will post strong results—but whether any

$Novo-Nordisk A/S(NVO)$ Novo Nordisk (NYSE: NVO), the Danish pharmaceutical giant behind blockbuster GLP-1 drugs like Ozempic and Wegovy, has seen its stock price take a surprising turn in recent months. After becoming a poster child for weight-loss and diabetes therapeutics and one of Europe’s most valuable companies, Novo Nordisk has endured a significant retreat in 2025. At one point trading near all-time highs above $140 per share, Novo has seen nearly half of its market value wiped out, with shares now hovering around the $75–$80 range as of early August 2025. This dramatic decline comes as a surprise to many investors who had viewed Novo as a near-unstoppable growth machine. With double-digit revenue growth, margin expansion, and a global add

Figma Freefall!!! Options Launch: Continue to Short? The recent surge in Figma $Figma(FIG)$  , with a reported 270% jump last week, has undeniably turned heads. This dramatic increase highlights the stock's volatility and has sparked widespread interest. However, the market's perspective that its current valuation might be excessively high introduces a note of caution. As someone not deeply versed in financial markets, this fluctuation suggests potential uncertainty on the horizon. Unlike Circle $Circle Internet Corp.(CRCL)$  , which benefits from cryptocurrency backing and appears to maintain momentum for continued speculation, Figma seems to lack these supporting factors. This contrast raises q

I'm watching $Advanced Micro Devices(AMD)$ Q2 earnings closely after a strong 46% YTD rally. While revenue is expected at $7.42B and EPS at $0.49, the key focus is how short-term issues in the data center business and export restrictions may impact results. These factors might weigh on Q2, but I’m more interested in AMD’s longer-term AI prospects. The upcoming MI350 and MI400 chips could be key drivers of future growth. Despite delays in MI300 shipments, AMD’s roadmap shows it’s still competitive in the AI space. Progress on export licenses could also support revenue in the coming quarters, even as gaming and embedded segments remain soft. The company’s ability to execute amid global headwinds will be crucial. I’m targeting $195 USD for AMD, exp

The recent plunge in Novo Nordisk's stock is a complex issue with several contributing factors, and whether it's a good time to "bottom fish" is a question with a nuanced answer that depends heavily on an individual investor's risk tolerance and long-term outlook. Here's a breakdown of the situation: Why the Stock Plunged  * Reduced Guidance and New CEO: The company recently cut its full-year sales and operating profit forecasts for the second time this year. This was coupled with the announcement of a new CEO. The revised outlook reflects a more challenging environment than previously expected.  * Competition and "Copycat" Drugs: Novo Nordisk's blockbuster weight-loss drug, Wegovy, is facing significant competition, particularly from "compounded" or copycat versions of the drug

Hello everyone! In today’s article, we’ll examine the recent performance of Microsoft Corp. ($MSFT) through the lens of Elliott Wave Theory. We’ll review how the rally from the July 23, 2025 low unfolded as a 5-wave impulse followed by a 3-swing correction (ABC) and discuss our forecast for the next move. Let’s dive into the structure and expectations for this stock. 5 Wave Impulse Structure + ABC correction $GOOGL $MSFT 1H Elliott Wave Chart 7.28.2025: $MSFTIn the 1-hour Elliott Wave count from July 28, 2025, we saw that $MSFT completed a 5-wave impulsive cycle at black ((i)). As expected, this initial wave prompted a pullback. We anticipated this pullback to unfold in 3 swings and find buyers in the equal legs area between $511.32 and $508.13 This setup aligns with a typical Elliott Wave